OncoImmune: Rockville biopharma to be acquired by Merck for $425M
The local company would also spin out certain assets unrelated to its Covid-19 program.
Read full article »
OncoImmune is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer and autoimmune diseases.
Read more